journal article

• A Highly Anticipated Selective Therapeutic Agent against CDK2: INX-315.  Cancer Discovery. 386-388. 2024
• Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity.  Cell. 2628-+. 2023
• Replication timing maintains the global epigenetic state in human cells.  Science. 371-+. 2021
• The RIF1-long splice variant promotes G1 phase 53BP1 nuclear bodies to protect against replication stress.  eLife. 2020